← Back to screener

COLLEGIUM PHARMACEUTICAL, INC COLL

Rank #474 · Nasdaq · $0.8B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
64.7
P/E
16.0
P/B
3.96
ROE
24.7%
Op. Margin
29.5%
Debt Ratio
736%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★☆☆
Good

P/E 16.0x, P/B 3.96x. Ranks in the top 39% of the universe.

Profitability ★★★★☆
Excellent

ROE 24.7%. Ranks in the top 14% of the universe.

Safety ★☆☆☆☆
Poor

Debt ratio 736%. Ranks in the top 85% of the universe. Above 200% signals meaningful leverage risk.

Growth ★★★★☆
Excellent

Revenue growth of 22.2% year over year. Ranks in the top 16% of the universe.

Profitability is the relative strength · Safety is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2015–$-0.0B$-0.0B$-0.1B–-28
2016–$-0.0B$-0.0B$0.1B–15
2017–$-0.0B$-0.0B$0.1B–20
2018$0.0B$-0.1B$-0.1B$0.1B-5498.730
2019$0.0B$-0.1B$-0.1B$0.1B-264.9218
2020$0.3B$-0.0B$-0.0B$0.1B-7.4250
2021$0.3B$-0.0B$-0.0B$0.1B-8.0500
2022$0.3B$0.1B$0.0B$0.1B18.1559
2023$0.3B$0.0B$0.1B$0.2B6.4526
2024$0.5B$0.0B$-0.0B$0.2B7.2467
2025$0.6B$0.2B$0.0B$0.2B29.5736

← See the full screener